Anti-Influenza A HA(Gedivumab Biosimilar) Antibody

Details and Advantages

Code: 400-379-001

Specification:

Applications: ELISA,Flow Cyt

Reactivity: Influenza A HA

Conjugate: Unconjugated

Advantages:

High lot-to-lot consistency Increased sensitivity and higher affinity Animal-free production

Product Description Manual MSDS FAQ Citations

Product Detail

Description:
Anti-Influenza A HA(Gedivumab Biosimilar) Antibody is a biosimilar antibody directed against Influenza A HA.

Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Influenza A HA
Clonality: Monoclonal
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5)
Storage: Store at –20 °C, (Avoid freeze/thaw cycles)

FAQ

Citations

Related Products

Anti-Zaire Ebolavirus Glycoprotein(Larcaviximab Biosimilar) Antibody

Anti-STEAP1(Vandortuzumab Biosimilar) Antibody

Anti-ICOS/CD278(Vopratelimab Biosimilar) Antibody

Anti-TIGIT/VSTM3(Lancastotug Biosimilar) Antibody

Anti-LAG3/CD223(Negalstobart Biosimilar) Antibody

Anti-IL31RA(Nemolizumab Biosimilar) Antibody

Anti-IL1B(Gevokizumab Biosimilar) Antibody

Anti-IL13(Cendakimab Biosimilar) Antibody